New DHSC Notices, 1 to 30 September 2026
- Methylprednisolone (Medrone) 100mg tablets, MSN/2026/041 (1 September): out of stock until the week of 5 October 2026. Methylprednisolone injections could cover extra demand, and unlicensed imports were sourced.
- Edoxaban (Lixiana) 15mg tablets, MSN/2026/042 (1 September): out of stock until mid-September 2026. Other direct-acting oral anticoagulants could cover extra demand.
- Ramipril 1.25mg, 2.5mg, 5mg and 10mg capsules, MSN/2026/043 (7 September): limited supply until the end of October 2026. Ramipril tablets stayed available but couldn't cover extra demand, and DHSC advised against routine switching to other ACE inhibitors or ARBs. This sits alongside SSP087 for the 1.25mg capsules.
- Lansoprazole 15mg and 30mg orodispersible tablets, MSN/2026/044 (7 September): limited supply until early January 2027. Lansoprazole gastro-resistant capsules could cover extra demand.
New SSPs
On 9 September 2026 NHSBSA issued SSP088 (lansoprazole 15mg orodispersible tablets) and SSP089 (lansoprazole 30mg orodispersible tablets), running to 15 January 2027. Both let a pharmacist limit a prescription for more than a month's supply to one month's worth. See the NHSBSA Serious Shortage Protocols table.
Expected Dates That Passed
On 1 September MediWatch took nabilone 1mg capsules (MSN/2026/032, expected back at the end of August 2026) off the active list because the expected date had passed with no update. That is not confirmation it is back in stock.
Archive published 27 October 2026 from MediWatch's shortage database; MSN numbers and dates are as issued. Series: August 2026 · October 2026 (latest).